Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy

JCI Insight. 2022 Oct 24;7(20):e165502. doi: 10.1172/jci.insight.165502.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / pathology
  • Humans
  • Immunotherapy / adverse effects
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factor-alpha